Evidence map›Paper›PMID 25192044›Full record

ArticleAmerican journal of human genetics2014

Transcriptome sequencing of a large human family identifies the impact of rare noncoding variants.

Xin Li, Alexis Battle, Konrad J Karczewski, Zach Zappala, David A Knowles, Kevin S Smith, Kim R Kukurba, Eric Wu, Noah Simon, Stephen B Montgomery

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Rare Variants in theDrug metabolism and disposition: the biological fate of chemicals · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xin LiDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: xxli@stanford.edu.
Alexis BattleDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Computer Science, Stanford University, Stanford, CA 94305, USA.
Konrad J KarczewskiDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Zach ZappalaDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
David A KnowlesDepartment of Computer Science, Stanford University, Stanford, CA 94305, USA.
Kevin S SmithDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Kim R KukurbaDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
Eric WuDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Noah SimonDepartment of Biostatistics, University of Washington, Seattle, WA 98195, USA.
Stephen B MontgomeryDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Computer Science, Stanford University, Stanford, CA 94305, USA. Electronic address: smontgom@stanford.edu.
Stanford University · USUniversity of Washington · US

Funding

INSTITUTIONAL TRAINING GRANT IN GENOME SCIENCET32HG000044 · NHGRI · STANFORD UNIVERSITY · PI MICHAEL P. SNYDER · 1995 to 2026
$32.2M
NHGRI NIH HHS T32 HG000044
6 · The paper itself

Abstract

Recent and rapid human population growth has led to an excess of rare genetic variants that are expected to contribute to an individual's genetic burden of disease risk. To date, much of the focus has been on rare protein-coding variants, for which potential impact can be estimated from the genetic code, but determining the impact of rare noncoding variants has been more challenging. To improve our understanding of such variants, we combined high-quality genome sequencing and RNA sequencing data from a 17-individual, three-generation family to contrast expression quantitative trait loci (eQTLs) and splicing quantitative trait loci (sQTLs) within this family to eQTLs and sQTLs within a population sample. Using this design, we found that eQTLs and sQTLs with large effects in the family were enriched with rare regulatory and splicing variants (minor allele frequency < 0.01). They were also more likely to influence essential genes and genes involved in complex disease. In addition, we tested the capacity of diverse noncoding annotation to predict the impact of rare noncoding variants. We found that distance to the transcription start site, evolutionary constraint, and epigenetic annotation were considerably more informative for predicting the impact of rare variants than for predicting the impact of common variants. These results highlight that rare noncoding variants are important contributors to individual gene-expression profiles and further demonstrate a significant capability for genomic annotation to predict the impact of rare noncoding variants.

Indexed as

Genome, HumanQuantitative Trait LociSequence Analysis, RNATranscriptomeFamilyHaplotypesHigh-Throughput Nucleotide SequencingHumansLymphocytesPolymorphism, Single NucleotideRNA, UntranslatedWhite PeopleRNA, Untranslated

Identifiers

PMID25192044
PMCPMC4157143
OpenAlexW2034901737

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.